[Ip-health] ATM Index - ARV Licensing
dedwards at atmindex.org
Mon Dec 1 12:36:14 PST 2014
For World Aids Day, the Access to Medicine Index conducted a short analysis of the licensing practices of the top 20 research-based pharmaceutical companies to assess how they are contributing through licensing to global efforts to combat HIV/AIDS.
Ending the epidemic requires a massive scale up of affordable ARVs, and licensing to generic manufacturers is an important part of this work.
Based on this analysis, we find that pharmaceutical companies need to license their ARVs to more generic medicine manufacturers, in more MICs, and - importantly - earlier in a product’s lifespan.
Link to article is here:
Access to Medicine Foundation
More information about the Ip-health